Summary
Overview
Work History
Education
Skills
Patents
Publications
Languages
Accomplishments
Certification
Skills (Operation based)
References
Timeline
Generic
Itishri Sahu

Itishri Sahu

Merelbeke

Summary

Experienced scientist with a strong background in research and analysis. Proficient in experimental design, data analysis, and interpretation across various scientific disciplines. Demonstrated ability to contribute to impactful research projects and collaborate effectively with interdisciplinary teams.

Overview

7
7
years of professional experience
1
1
Certification

Work History

Program Lead MRNA/saRNA Cancer Therapy

Ziphius
Merelbeke
01.2023 - Current
  • Created tailored saRNA/mRNA constructs optimized for CAR delivery in NK cells, enabling precise targeting of solid tumors such as Pancreatic adenocarcinoma.
  • Designed and implemented unique method for efficient delivery of nucleic acid (saRNA/mRNA) into NK cells utilizing lipid nanoparticles/lipoplexes.
  • Conducted regular meetings with internal and external team members to review progress and address any issues or concerns arising from the program execution process.
  • Participated actively in brainstorming sessions focused on improving existing processes or creating innovative approaches for delivering project outcomes more efficiently.
  • Collaborated with teams across departments to develop effective strategies for executing programs.

Program Lead (Prophylactic Vaccine)

Ziphius
Belgium
05.2020 - Current
  • Designed and optimized a saRNA-based vaccine with dual antigens to provoke a comprehensive and robust immune reaction against SARS-CoV2.
  • Carried out toxicological and efficacy assessment by conducting late preclinical studies using suitable animal models such as Hamsters, Rats, and Non Human primates.
  • Partnered with CMC to optimize QC assay development and readouts for drug substance and product.
  • Led multiple research projects, extracting insights from data analysis and formulating conclusions.
  • Guided junior scientists on implementing best practices in experiment execution, data interpretation, and delivering presentations.
  • Summarized research progress in reports for stakeholders and grant authorities.

Post Doc

European Research Council
Tuebingen
01.2018 - 01.2020
  • Management of highly challenging projects of mRNA-based gene supplementation for lung diseases (Cystic fibrosis and surfactant Protein B deficiency)
  • Formulating and Testing CRISPR/Cas based gene editing tools in-vitro and in-vivo for monogenetic diseases.

Education

Ph.D. - Biochemistry And Molecular Biology

University Tübingen & University of Hyderabad
Germany And India
09-2018

Masters of Technology - Bioinformatics

University of Hyderabad
India
07-2012

Bachelor of Technology - Biotechnology

Jawaharlal Nehru Technological University
India
05-2010

Skills

  • IVT RNA production and analytics
  • Molecular biology techniques for RNA and protein
  • LNP formulation (microfluidics)
  • Animal
  • FELASA-B
  • In vivo imaging (IVIS)
  • Biodistribution
  • Toxicology in Non- Human Primates and rodents
  • Flexivent (Lung function)
  • IV, IM, IP and ID administration
  • Bioinformatics/ software tools
  • Protein Modelling and drug designing (Modeller, Discovery studio)
  • Microsoft office suite

Patents

  • Self-replicating RNA molecules comprising a sequence encoding non-structural alphavirus proteins and a sequence encoding a SARS-CoV-2 (WO2021255270A1)
  • Patent 1 for ionizable lipids for saRNA/mRNA: Lipid nanoparticles for oligonucleotide delivery (WO2023078954A1)
  • Patent 2 for ionizable lipids for saRNA/mRNA: Lipid nanoparticles for oligonucleotide delivery (WO2023078950A1)
  • Patent 3 for ionizable lipids for saRNA/mRNA: Lipid nanoparticles for oligonucleotide delivery (WO2023078946A1)

Publications

  • A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity, Molecular Therapy, 2022, Sean McCafferty, A.K.M. Ashiqul Haque, Aster Vandierendonck, Brian Weidensee, Magalie Plovyt, Magdalena Stuchlíková, Nathalie François, Sophie Valembois, Leo Heyndrickx, Johan Michiels, Kevin K. Ariën, Linos Vandekerckhove, Rana Abdelnabi, Caroline S. Foo, Johan Neyts, Itishri Sahu, Niek N. Sanders
  • Beta Glycerophosphate- Induced ORAI1 Expression and Store Operated Ca2+ Entry in Megakaryocytes, Sci Rep, 2020, Pelzl L, Sahu I, K Ma, Heizmann D, Al Mamun Bhuyan A, Al Maghout T, Sukkar B, Sharma Y, Marinin I, Rigoni F, Artunc F, Cao H, Ravi Gutti, Voelkl J, Pieske B, Gawaz M, Bakchoul T, Lang F
  • Recent developments in mRNA-based protein supplementation therapy to target lung diseases, Mol Ther, 2019, Sahu I, AKM Ashiqul Haque, Brian Weidensee, Petra Weinmann, Kormann MSD
  • MicroRNA function in megakaryocytes, Platelets, 2018, Raghuwanshi S, Dahariya S, Musvi SS, Gutti U, Kandi R, Undi RB, Sahu I, Gautam DK, Paddibhatla I, Gutti RK
  • Systems biology approach to study the role of miRNA in promoter targeting during megakaryopoiesis, Exp. Cell Res., 2018, Sahu I, Hebalkar R, Kar S, Ts S, Gutti U, Gutti RK
  • NFAT5-sensitive Orai1 expression and store-operated Ca2+ entry in megakaryocytes, FASEB J., 2017, Sahu I, Pelzl L, Sukkar B, Fakhri H, Al-Maghout T, Cao H, Hauser S, Gutti R, Gawaz M, Lang F
  • Lithium Sensitive ORAI1 Expression, Store Operated Ca2+ Entry and Suicidal Death of Neurons in Chorea-Acanthocytosis, Sci Rep., 2017, Pelzl L, Hauser S, Elsir B, Sukkar B, Sahu I, Singh Y, Höflinger P, Bissinger R, Jemaà M, Stournaras C, Schöls L, Lang F
  • Role of Na+/Ca2+ exchangers in therapy resistance of medulloblastoma cells, Cell Physiol Biochem., 2017, Pelzl L, Hosseinzadeh Z, al-Maghout T, Sing Y, Sahu I, Bissinger R, Schmidt S, Alkahtani S, Stournaras C, Toulany M, Lang F
  • Sequence and structural difference favor a distinct preference of Wnt3a binding with coreceptor LRP6, J Biomol Struct Dyn., 2015, Sahu I, Mishra S, Undi R, Kandi R, Gutti U, Gutti RK
  • MiR-196b-mediated translation regulation of mouse insulin2 via the 5'UTR, PLoS One, 2014, Panda AC, Sahu I, Kulkarni SD, Martindale JL, Abdelmohsen K, Vindu A, Joseph J, Gorospe M, Seshadri V

Languages

English
Proficient (C2)
C2
Dutch
Elementary (A2)
A2

Accomplishments

  • VLAIO grant CAR-NK cell therapy (0.4 Mil Euro)- Granted Dec 2023 HBC.2023.0682.
  • VLAIO grant RSV (0.3 Mil Euro)- Granted Dec 2022 HBC.2022.0729.
  • Award for Research proficiency 2019 by School of Life sciences, UoH.
  • Best Poster- 6th International Lung health by ERS
  • DAAD Fellowship, Germany (2015-2017).
  • Awarded Senior Research Fellowship from Center for Scientific and Industrial research, India.

Certification

  • Project Management- Vlerick Business School
  • FELASA-B

Skills (Operation based)

  • Operations oversight.
  • Innovation management.
  • Strategic planning.
  • Data interpretation.
  • Attention to details.
  • Resource Management.
  • Problem solving abilities.
  • Cross functional team coordination.
  • MS Projects.

References

References available upon request.

Timeline

Program Lead MRNA/saRNA Cancer Therapy

Ziphius
01.2023 - Current

Program Lead (Prophylactic Vaccine)

Ziphius
05.2020 - Current

Post Doc

European Research Council
01.2018 - 01.2020

Ph.D. - Biochemistry And Molecular Biology

University Tübingen & University of Hyderabad

Masters of Technology - Bioinformatics

University of Hyderabad

Bachelor of Technology - Biotechnology

Jawaharlal Nehru Technological University
Itishri Sahu